Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gilead, Galapagos’ filgotinib succeeds in phase 3 rheumatoid arthritis study
Image: Gilead Sciences and Galapagos’ filgotinib has succeeded in phase 3 rheumatoid arthritis study. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.
Image: Gilead Sciences and Galapagos’ filgotinib has succeeded in phase 3 rheumatoid arthritis study. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.